October 29, 2026

Medical Research and Clinical Trials

Landmark Discovery Unlocks Secrets of Aggressive Brain Cancer, Offering Hope for Earlier Diagnosis and Smarter Treatments landmark-discovery-unlocks-secrets-of-aggressive-brain-cancer-offering-hope-for-earlier-diagnosis-and-smarter-treatments

Landmark Discovery Unlocks Secrets of Aggressive Brain Cancer, Offering Hope for Earlier Diagnosis and Smarter Treatments

Reynand Wu September 13, 2026
London, UK – September 8, 2023 – In a groundbreaking revelation that could transform the fight against...
Read More Read more about Landmark Discovery Unlocks Secrets of Aggressive Brain Cancer, Offering Hope for Earlier Diagnosis and Smarter Treatments
BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results biomarin-submits-new-drug-application-for-voxzogo-in-hypochondroplasia-following-promising-phase-iii-trial-results

BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results

Ammar Sabilarrohman September 13, 2026
San Rafael, CA – October 26, 2023 – BioMarin Pharmaceutical Inc. has announced a significant milestone in...
Read More Read more about BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results
Landmark Study Unveils Breakthrough in Targeting Aggressive Prostate Cancer with Combination Therapy landmark-study-unveils-breakthrough-in-targeting-aggressive-prostate-cancer-with-combination-therapy

Landmark Study Unveils Breakthrough in Targeting Aggressive Prostate Cancer with Combination Therapy

Sagoh September 12, 2026
LONDON, UK – In a significant stride towards personalized medicine for advanced prostate cancer, an international Phase...
Read More Read more about Landmark Study Unveils Breakthrough in Targeting Aggressive Prostate Cancer with Combination Therapy
Bionyra Pharma Initiates Phase I Trial for Novel Atopic Dermatitis Therapy BYN-001, Targeting Upstream Inflammatory Pathway bionyra-pharma-initiates-phase-i-trial-for-novel-atopic-dermatitis-therapy-byn-001-targeting-upstream-inflammatory-pathway

Bionyra Pharma Initiates Phase I Trial for Novel Atopic Dermatitis Therapy BYN-001, Targeting Upstream Inflammatory Pathway

Evan Lee Salim September 12, 2026
Melbourne, Australia – [Insert Date] – Bionyra Pharma has announced a significant advancement in its development pipeline...
Read More Read more about Bionyra Pharma Initiates Phase I Trial for Novel Atopic Dermatitis Therapy BYN-001, Targeting Upstream Inflammatory Pathway

You may have missed

a-new-era-in-brain-tumour-diagnosis-nottingham-breakthrough-slashes-wait-times-to-hours-revolutionising-patient-care

A New Era in Brain Tumour Diagnosis: Nottingham Breakthrough Slashes Wait Times to Hours, Revolutionising Patient Care

Rifan Muazin October 29, 2026
esmo26-iza-bren-leads-post-tki-adcs-on-efficacy-but-toxicity-could-decide

ESMO26: Iza-bren leads post-TKI ADCs on efficacy, but toxicity could decide

Nila Kartika Wati October 29, 2026
navigating-childhood-reactions-a-guide-for-parents-facing-cancer

Navigating Childhood Reactions: A Guide for Parents Facing Cancer

Suro Senen October 29, 2026
beyond-the-finish-line-danielle-gabriels-journey-from-a-stage-ii-diagnosis-to-the-nyc-marathon

Beyond the Finish Line: Danielle Gabriel’s Journey from a Stage II Diagnosis to the NYC Marathon

Suro Senen October 29, 2026